tiprankstipranks
Agios Pharma (GB:0HB0)
LSE:0HB0
UK Market

Agios Pharma (0HB0) Technical Analysis

Compare
1 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Agios Pharma’s (0HB0) Moving Averages Convergence Divergence (MACD) indicator is -0.50, suggesting Agios Pharma is a Buy.
Agios Pharma’s (0HB0) 20-Day exponential moving average is 33.64, while Agios Pharma’s (0HB0) share price is $31.71, making it a Sell.
Agios Pharma’s (0HB0) 50-Day exponential moving average is 35.44, while Agios Pharma’s (0HB0) share price is $31.71, making it a Sell.

Agios Pharma (0HB0) Pivot Points

Mar 12, 2025, 03:48 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
31.20
31.37
31.73
31.90
32.26
32.43
32.79
Fibonacci
31.37
31.58
31.70
31.90
32.11
32.23
32.43
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Agios Pharma (0HB0) Moving Averages

Mar 12, 2025, 03:48 PM
Period
Simple
Exponential
MA5
32.93Sell
32.70Sell
MA10
33.58Sell
33.25Sell
MA20
33.73Sell
33.64Sell
MA50
33.69Sell
35.44Sell
MA100
41.40Sell
38.21Sell
MA200
43.07Sell
38.86Sell
Agios Pharma’s (0HB0) 10-Day exponential moving average is 33.25, while Agios Pharma’s (0HB0) share price is $31.71, making it a Sell.
Agios Pharma’s (0HB0) 100-Day exponential moving average is 38.21, while Agios Pharma’s (0HB0) share price is $31.71, making it a Sell.
Agios Pharma’s (0HB0) stock price is $31.71 and Agios Pharma’s (0HB0) 50-day simple moving average is 33.69, creating a Sell signal.
Agios Pharma’s (0HB0) stock price is $31.71 and Agios Pharma’s (0HB0) 100-day simple moving average is 41.40, creating a Sell signal.
Agios Pharma’s (0HB0) stock price is $31.71 and Agios Pharma’s (0HB0) 200-day simple moving average is 43.07, creating a Sell signal.

Agios Pharma (0HB0) Technical Indicators

Mar 12, 2025, 03:48 PM
Name
Value
Implied Action
RSI (14)
38.90
Neutral
STOCH (9,6)
20.28
Neutral
STOCHRSI (14)
16.64
Buy
MACD (12,26)
-0.50
Buy
ADX (14)
13.53
Buy
Williams %R
-96.64
Buy
CCI (14)
-170.05
Buy
ATR (14)
1.15
-
Ultimate Oscillator
40.26
Neutral
ROC
-6.21
Sell
Agios Pharma’s (0HB0) Relative Strength Index (RSI) is 38.90, creating a Neutral signal.
Agios Pharma’s (0HB0) Trend Strength Indicator (ADX) is 13.53, creating a Buy signal.
Agios Pharma’s (0HB0) Commodity Channel Index (CCI) is -170.05, creating a Buy signal.
Agios Pharma’s (0HB0) Price Rate of Change (ROC) is -6.21, creating a Sell signal.

FAQ

Is 0HB0 a Buy, Hold, or Sell?
Based on 0HB0’s technical indicators, 0HB0 is a Sell.
    What is 0HB0’s RSI (14)?
    0HB0’s RSI (14) is 38.90, which suggests 0HB0 is a Neutral.
      What is 0HB0’s MACD?
      0HB0’s MACD is -0.50, which suggests 0HB0 is a Buy.
        What is 0HB0’s 5-day moving average?
        0HB0’s 5-day moving average is 32.93, which suggests 0HB0 is a Sell.
          What is 0HB0’s 20-day moving average?
          0HB0 20-day moving average is 33.73, which suggests 0HB0 is a Sell.
            What is 0HB0’s 50-day moving average?
            0HB0’s 50-day moving average is 33.69, which suggests 0HB0 is a Sell.
              What is 0HB0’s 200-day moving average?
              0HB0’s 200-day moving average is 43.07, which suggests 0HB0 is a Sell.
                What is 0HB0’s Williams % R (14)?
                0HB0’s Williams % R (14) is -96.64, which suggests 0HB0 is a Buy.
                  What is 0HB0’s CCI (14)?
                  0HB0’s CCI (14) is -170.05, which suggests 0HB0 is a Buy.
                    What is the share price of Agios Pharma?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis